Cytosorbents Corporation

NASDAQ: CTSO · Real-Time Price · USD
0.88
0.07 (8.90%)
At close: May 15, 2025, 2:22 PM
8.90%
Bid 0.87
Market Cap 54.8M
Revenue (ttm) 37.44M
Net Income (ttm) -20.72M
EPS (ttm) -0.38
PE Ratio (ttm) -2.3
Forward PE -6.29
Analyst Buy
Ask 0.88
Volume 35,045
Avg. Volume (20D) 108,452
Open 0.84
Previous Close 0.81
Day's Range 0.84 - 0.90
52-Week Range 0.70 - 1.61
Beta 1.18

About CTSO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTSO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CTSO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Cytosorbents has released their quartely earnings on May 14, 2025:
  • Revenue of $8.73M exceeds estimates by $627.24K, with -10.83% YoY decline.
  • EPS of -0.06 exceeds estimates by 0.02, with 50.00% YoY growth.
  • 7 months ago
    -10%
    CytoSorbents shares are trading lower. The company... Unlock content with Pro Subscription
    9 months ago
    +17.48%
    Cytosorbents shares are trading higher after EF Hutton initiated coverage on the stock with a Buy rating and announced a price target of $10.